Erratum | Open | Published:
Erratum to: Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma
Journal for ImmunoTherapy of Cancervolume 4, Article number: 74 (2016)
The original article was published in Journal for ImmunoTherapy of Cancer 2016 4:28
Unfortunately, after publication of this article , it was noticed that a funding source was not mentioned. Bristol-Myers Squibb was intended to be included in the ‘Financial Support’ section of the article.
Patel MA, Kim JE, Theodros D, Tam A, Velarde E, Kochel CM, Francica B, Nirschl TR, Ghasemzadeh A, Mathios D, Harris-Bookman S, Jackson CC, Jackson C, Ye X, Tran PT, Tyler B, Coric V, Selby M, Brem H, Drake CG, Pardoll DM, Lim M. Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma. J Immunothera Cancer. 2016;4:28. doi:10.1186/s40425-016-0132-2.
The online version of the original article can be found under doi:10.1186/s40425-016-0132-2.